Brian Lasky

Senior Principal in the IMS Consulting Group. He has over 15 years of experience in the pharma and biotechnology sectors and is considered to be a global thought leader in the diabetes market.

Who Will Win the Diabetes Drug Competition?

With the prevalence of Type 2 Diabetes rising globally, anti-diabetics will continue to outperform ...